Professor of medicine and public health; associate vice chancellor for population health sciences
What is the best asthma treatment for African Americans?
How can we improve treatment of uncontrolled asthma in children visiting the emergency department?
How can we help patients stick to their treatment plans after they leave the hospital?
What can I do to reduce my risk of COVID-19?
These are just some of the questions Dr. Jerry Krishnan, professor of medicine and public health and associate vice president for population health sciences at UI Health, hopes to answer through several ongoing clinical studies.
Krishnan is a physician-scientist with expertise in the care of patients with asthma, chronic obstructive pulmonary disease and other lung disorders. He is a principal investigator of multiple clinical trials supported by grants from the National Institutes of Health and the Patient-Centered Outcomes Research Institute that focus on identifying the most effective treatments and educational and support programs to improve health outcomes for patients with pulmonary disorders.
Krishnan was chairman of the Pulmonary-Allergy Drugs Advisory Committee for the U.S. Food and Drug Administration. He is a member of the National Committee for Quality Assurance Respiratory Measurement Advisory Panel, and the National Heart, Lung, and Blood Institute’s Clinical Trials Review Committee.
- Population health
- COVID-19 treatment and vaccines
- Chronic obstructive pulmonary disease (COPD)
- Clinical trials
- Evidence-based medicine and clinical guidelines
- Application of human-centered design to healthcare
- Respiratory health
- Public Health
In the News
November 18, 2020
May 9, 2019
April 23, 2019